Business Description
Context Therapeutics is a Philadelphia-based drug development company focused on finding new ways to treat solid tumor cancers. Its main drug candidate, CTIM-76, is designed to harness the body's own immune cells to seek out and destroy cancer cells that carry a specific protein called Claudin 6. The company works alongside Integral Molecular to advance this approach through a shared licensing and development agreement.
